Wall Street Analysts Think Burford Capital (BUR) Could Surge 42.55%: Read This Before Placing a Bet
The mean of analysts' price targets for Burford Capital (BUR) points to a 42.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ...
Wall Street Analysts See a 70.33% Upside in Arcutis Biotherapeutics (ARQT): Can the Stock Really Move This High?
The consensus price target hints at a 70.3% upside potential for Arcutis Biotherapeutics (ARQT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...